News
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
3dOpinion
The gene therapy chief wanted to block fast-track drug approvals.
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory ...
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
His resignation follows mounting political attacks from Trump supporters, who scrutinized his past views on COVID-19 policies ...
The U.S. Food and Drug Administration's top official, Vinay Prasad, has left the agency after nearly three months as Director ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results